Med BioGene - Corporate Information

Corporate Information Leadership Team

Featured News

February 17, 2010

Med BioGene Announces Results of Annual and Special Meeting

January 18, 2010

Med BioGene Appoints World-Renowned Genticist Dr. Michael R. Hayden as Director

December 29, 2009

Med BioGene Files Registration Statement for Proposed U.S. IPO

December 03, 2009

Med BioGene Announces Poster Presentations of LungExpress Dx™ Validation Study and Health Economics Evaluation at AACR – IASLC Meeting in January

Home

About Us

Corporate Information

Med BioGene was founded in 2002 and its state-of-the-art laboratory and offices are located in Discovery Park on the University of British Columbia campus. Med BioGene's common shares are listed on the TSX Venture Exchange under the symbol "MBI".

E-MAIL ALERTS

Subscribe to our e-mail news alerts